A pharma giant is moving past one patent cliff — but another is already looming
· cnbc.com · popularity 48/100 · 0 similar stories today · Pharmaceuticals & Medical Research (Health & Life Sciences)
Read the original at cnbc.com →
Summary
Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
Found in: Health, CNBC Top News. Rating basis: single outlet; outlet tier 5; 2 feeds; listed 2 times; feed position 3.